Arrow Investment Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-688
Closed -$209K 56
2023
Q2
$209K Buy
+688
New +$191K 0.16% 37
2022
Q2
Sell
-896
Closed -$224K 67
2022
Q1
$224K Sell
896
-243
-21% -$61K 0.17% 72
2021
Q4
$293K Buy
1,139
+38
+3% +$9.3K 0.21% 34
2021
Q3
$267K Sell
1,101
-297
-21% -$72.6K 0.18% 64
2021
Q2
$289K Buy
+1,398
New +$285K 0.18% 72

Other funds holding HCA

Arrow Investment Advisors's HCA Position: Q3 2023 in Review

Arrow Investment Advisors sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 688 shares — an estimated $209K sold.

Arrow Investment Advisors first reported a position in HCA in Q2 2021 and held it in 5 quarters. The position peaked at $293K in Q4 2021. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

  • Arrow Investment Advisors reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
  • Arrow Investment Advisors sold 688 HCA Healthcare shares in Q3 2023, an estimated $209K.
  • Arrow Investment Advisors first reported a position in HCA Healthcare in Q2 2021 and held it in 5 quarters.
  • Arrow Investment Advisors's HCA Healthcare position peaked at $293K in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Arrow Investment Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.